The State of Texas has sued pharmaceutical firm Eli Lilly & Firm Inc., alleging the corporate engaged in improper practices to affect medical suppliers to prescribe its most commercially profitable medication, together with the GLP-1 medicines Mounjaro and Zepbound, that are indicated for weight reduction and diabetes administration.
Trending
- Moragh Bradshaw obituary | Volunteering
- New album, Travis Kelce relationship
- Economic woes dominate as Bolivia prepares to go to the polls
- Incoming ABA President Michelle Behnke to prioritize defending liberty, pursuing justice
- MSNBC Has Growth, Fox News Still No. 1
- TikTok Adds AI Avatar Stickers, Expanding its AI Toolset
- Sling TV’s new flexible live TV deals are great for dodging subscriptions and should be the future of streaming services
- The Disease that Accelerates Aging in Kids
Texas Sues Eli Lilly: ‘Big Pharma Compromised Medical Decision-Making’
